Key clinical trial weight loss results non-diabetic adults with obesity Semaglutide 2.4 mg (Wegovy) STEP 1 68 weeks n=1,961 ~15% mean weight loss ~33% achieved 20% loss vs 2.4% placebo Tirzepatide 15 mg (Zepbound) SURMOUNT-1 72 weeks n=2,539 ~21% mean weight loss ~57% achieved 20% loss vs 3.1% placebo Head-to-head SURMOUNT-5 (2025) 72 weeks direct comparison ~6 percentage point advantage for tirzepatide over semaglutide statistically significant Fig
The medication requires gradual dose titration over several months to minimize gastrointestinal side effects, which are the most common tolerability concerns
Almonds and sunflower seeds are both considered powerhouse foods when it comes to boosting energy, but they do so in different ways because of their unique nutrient compositions
Hadidchi also emphasizes the importance of combining medication with healthy lifestyle changes, such as diet and exercise, to maximize the results of the treatment
A peptide blend combines two or more therapeutic peptides that may complement each other to achieve multiple goals at once such as fat loss, muscle growth, tissue repair, and hormone support
